Sanofi's plans for OTC Cialis hit a snag in US

It has been eight years since Sanofi licensed rights to an over-the-counter version of erectile dysfunction (ED) drug Cialis from Eli Lilly, and the FDA has just thrown a spanner into its p

Takeda to sell European OTC business to cut debts

Japan’s Takeda has said it would sell up to $670 million of over-the-counter (OTC) drug operations in Europe to cut its debts.

Stada expands OTC business with portfolio of GSK drugs

Germany’s Stada is to expand its over-the-counter business after agreeing to buy a portfolio of consumer health products from GlaxoSmithKline.

Takeda nets $660m from product selloff to Germany’s Stada

GSK/Pfizer form consumer health joint venture

GlaxoSmithKline has announced its second major deal this month, signing an agreement with Pfizer to combine its consumer health business and form a joint venture with combined annual sales

P&G buys Merck KGaA's consumer health unit for $4.2bn

Merck KGaA is to sell its consumer health business to Procter and Gamble for $4.2 billion, continuing the trend for big pharma companies to rethink their investment in over-the-counter prod